semaglutide in heart failure #hfpef #obesity #esccongress | European Society of Cardiology Weight loss drug's heart benefits

45 Products that are a combination of a DPP-4 inhibitor and an SGLT2 inhibitor (sitagliptin/ertugliflozin, saxagliptin/dapagliflozin, and linagliptin/empagliflozin) may be used to further lower A1C and provide increased CV benefit in patients who are not meeting A1C goals on dual therapy

Matching vial size to your dosing schedule If your compounding pharmacy offers multiple vial sizes, choose one that matches your weekly dose and your BUD

Presented in easy-to-carry sachets, this refreshing daily shot is designed to support an active lifestyle and overall wellness

Remove the plastic flip-caps from both the semaglutide vial and the bacteriostatic water vial